$1.51 Billion is the total value of Frazier Life Sciences Management, L.P.'s 52 reported holdings in Q3 2023. The portfolio turnover from Q2 2023 to Q3 2023 was 0.0% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
HILLEVAX INC | $131,560,798 | -21.8% | 9,781,472 | 0.0% | 8.74% | -13.0% | ||
PHAT | PHATHOM PHARMACEUTICALS INC | $104,833,223 | -27.6% | 10,109,279 | 0.0% | 6.96% | -19.5% | |
PCVX | VAXCYTE INC | $59,361,367 | +2.1% | 1,164,405 | 0.0% | 3.94% | +13.5% | |
ARQT | ARCUTIS BIOTHERAPEUTICS INC | $46,113,272 | -44.3% | 8,684,232 | 0.0% | 3.06% | -38.0% | |
ALPN | ALPINE IMMUNE SCIENCES INC | $34,186,918 | +11.4% | 2,985,757 | 0.0% | 2.27% | +23.9% | |
TARS | TARSUS PHARMACEUTICALS INC | $31,764,355 | -1.7% | 1,787,527 | 0.0% | 2.11% | +9.4% | |
KALV | KALVISTA PHARMACEUTICALS INC | $31,190,212 | +7.0% | 3,238,859 | 0.0% | 2.07% | +19.0% | |
DISC MEDICINE INC | $30,771,900 | +5.8% | 655,000 | 0.0% | 2.04% | +17.7% | ||
MRUS | MERUS N V | $17,601,975 | -10.4% | 746,479 | 0.0% | 1.17% | -0.4% | |
ANAB | ANAPTYSBIO INC | $16,158,612 | -11.7% | 899,700 | 0.0% | 1.07% | -1.8% | |
TRVI | TREVI THERAPEUTICS INC | $15,000,776 | -8.8% | 6,881,090 | 0.0% | 1.00% | +1.4% | |
COGT | COGENT BIOSCIENCES INC | $14,638,484 | -17.7% | 1,501,383 | 0.0% | 0.97% | -8.5% | |
TYRA BIOSCIENCES INC | $14,155,739 | -19.1% | 1,028,013 | 0.0% | 0.94% | -10.1% | ||
ORIC | ORIC PHARMACEUTICALS INC | $12,964,273 | -22.0% | 2,142,855 | 0.0% | 0.86% | -13.3% | |
AUTL | AUTOLUS THERAPEUTICS PLCspon ads | $8,730,177 | -2.1% | 3,746,857 | 0.0% | 0.58% | +8.8% | |
SLN | SILENCE THERAPEUTICS PLCads | $8,661,931 | +78.7% | 881,173 | 0.0% | 0.58% | +99.0% | |
CERE | CEREVEL THERAPEUTICS HLDNG I | $8,579,190 | -31.3% | 393,000 | 0.0% | 0.57% | -23.6% | |
MGNX | MACROGENICS INC | $8,402,931 | -12.9% | 1,803,204 | 0.0% | 0.56% | -3.1% | |
REPL | REPLIMUNE GROUP INC | $6,617,498 | -26.3% | 386,762 | 0.0% | 0.44% | -17.9% | |
NTLA | INTELLIA THERAPEUTICS INC | $6,440,488 | -22.5% | 203,684 | 0.0% | 0.43% | -13.7% | |
PRTA | PROTHENA CORP PLC | $6,171,175 | -29.3% | 127,900 | 0.0% | 0.41% | -21.5% | |
THESEUS PHARMACEUTICALS INC | $6,047,642 | -71.2% | 2,248,194 | 0.0% | 0.40% | -67.9% | ||
ARVN | ARVINAS INC | $5,603,901 | -20.9% | 285,331 | 0.0% | 0.37% | -12.1% | |
BLUE | BLUEBIRD BIO INC | $5,198,117 | -7.6% | 1,709,907 | 0.0% | 0.34% | +2.7% | |
DCPH | DECIPHERA PHARMACEUTICALS IN | $4,706,400 | -9.7% | 370,000 | 0.0% | 0.31% | +0.6% | |
STRO | SUTRO BIOPHARMA INC | $2,706,600 | -25.4% | 780,000 | 0.0% | 0.18% | -17.1% | |
ACRS | ACLARIS THERAPEUTICS INC | $1,810,982 | -33.9% | 264,377 | 0.0% | 0.12% | -26.8% | |
ADCT | ADC THERAPEUTICS SA | $1,477,386 | -58.3% | 1,647,030 | 0.0% | 0.10% | -53.6% | |
NEWAMSTERDAM PHARMA COMPANY*w exp 11/22/202 | $950,633 | -9.1% | 500,333 | 0.0% | 0.06% | +1.6% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-11-14
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
ARCUTIS BIOTHERAPEUTICS INC | 7 | Q3 2023 | 17.0% |
MIRUM PHARMACEUTICALS INC | 7 | Q3 2023 | 13.6% |
PHATHOM PHARMACEUTICALS INC | 7 | Q3 2023 | 8.6% |
KRYSTAL BIOTECH INC | 7 | Q3 2023 | 7.6% |
SYNDAX PHARMACEUTICALS INC | 7 | Q3 2023 | 6.3% |
VAXCYTE INC | 7 | Q3 2023 | 4.8% |
CRINETICS PHARMACEUTICALS IN | 7 | Q3 2023 | 3.1% |
ALPINE IMMUNE SCIENCES INC | 7 | Q3 2023 | 3.2% |
TARSUS PHARMACEUTICALS INC | 7 | Q3 2023 | 2.5% |
KALVISTA PHARMACEUTICALS INC | 7 | Q3 2023 | 2.1% |
View Frazier Life Sciences Management, L.P.'s complete holdings history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-02-14 |
13F-HR | 2023-11-14 |
13F-HR | 2023-08-14 |
13F-HR | 2023-05-15 |
13F-HR/A | 2023-02-07 |
13F-HR | 2023-02-03 |
13F-HR | 2022-11-14 |
13F-HR | 2022-08-10 |
13F-HR | 2022-05-16 |
View Frazier Life Sciences Management, L.P.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.